SCHEMBL7108696

SCHEMBL7108696

N#Cc1nc(Cl)ccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.39
ALDH1A1 P00352 4/20 0.39
POLB P06746 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
PSMB8 P28062 4/20 0.36
ALOX15 P16050 3/20 0.36
MBOAT4 Q96T53 1/20 0.35
USP8 P40818 2/20 0.33
USP7 Q93009 2/20 0.33
KMO O15229 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ERBB2 P04626 1/20 0.33
USP47 Q96K76 1/20 0.33
BCAT1 P54687 1/20 0.33
PSMB5 P28074 1/20 0.32
GAA P10253 2/20 0.32
NPC1 O15118 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30450356 1.00 KDM4E (0.39) KDM4EALDH1A1POLBCRHBPCRHR2
Ammonia Solution, Strong SCHEMBL28870434 0.98 KDM4E (0.38) KDM4EALDH1A1POLBCRHBPCRHR2
SCHEMBL31661428 0.82 MBOAT4 (0.39) KDM4EALDH1A1POLBPSMB8ALOX15
SCHEMBL2708620 0.79 RPS6KA5 (0.39) KDM4EALDH1A1POLBMBOAT4USP8
SCHEMBL2792945 0.79 KDM4E (0.38) KDM4EALDH1A1POLBPSMB8ALOX15
SCHEMBL10960474 0.77 KDM4E (0.33) KDM4EALDH1A1POLBALOX15USP8
SCHEMBL1006497 0.77 KDM4E (0.33) KDM4EALDH1A1POLBALOX15MBOAT4
SCHEMBL31167609 0.77 ALDH1A1 (0.41) KDM4EALDH1A1POLBALOX15USP8
SCHEMBL3399707 0.77 KHK (0.36) KDM4EALDH1A1POLBPSMB8ALOX15
SCHEMBL13291167 0.77 ALDH1A1 (0.33) KDM4EALDH1A1POLBALOX15USP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106243027-B A kind of preparation method of 3,6- dichloro-2-pyridyl carboxylic acid 南京红太阳生物化学有限责任公司 2019-03-05 CN claimed
CN-106243027-A A kind of preparation method of 3,6 dichloro 2 picolinic acids 南京红太阳生物化学有限责任公司 2016-12-21 CN claimed
US-4766219-A Preparation of 2-cyano-6-chloropyridine compounds THE DOW CHEMICAL COMPANY (US) 1988-08-23 US claimed
EP-4709480-A1 5,6-FUSED BICYCLIC AMIDES AND COMPOSITIONS FOR USE AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS Amgen Inc. (US) 2026-03-18 EP disclosed
CN-113912533-B Method for preparing 3, 6-dichloropicolinic acid 西安凯立新材料股份有限公司 2023-06-20 CN disclosed
CN-113912533-A Method for preparing 3, 6-dichloropicolinic acid 西安凯立新材料股份有限公司 2022-01-11 CN disclosed
US-10617675-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2020-04-14 US disclosed
CN-106243027-B A kind of preparation method of 3,6- dichloro-2-pyridyl carboxylic acid 南京红太阳生物化学有限责任公司 2019-03-05 CN disclosed
US-20180221342-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-08-09 US disclosed
US-9994591-B2 Oxadiazolopyridine derivates for use as ghrelin O-acyl transferase (GOAT) inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2018-06-12 US disclosed
US-20180037594-A1 Oxadiazolopyridine Derivates for Use as Ghrelin O-Acyl Transferase (GOAT) Inhibitors BOEHRINGER INGELHEIM INERNATIONAL GMBH (DE) 2018-02-08 US disclosed
US-6043282-A FUNGICIDES, PESTICIDES, INSECTICIDES, NEMATOCIDES, MITICIDES BASF AKTIENGESELLSCHAFT (DE) 2000-03-28 US disclosed
EP-0949248-A1 6-(NONSUBSTITUTED OR SUBSTITUTED) PHENOXYPICOLINIC ACIDS, PROCESS OF PREPARING THE SAME, AND AGRICULTURAL/HORTICULTURAL GERMICIDES CONTAINING THE SAME KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1999-10-13 EP disclosed
EP-0882025-A1 PYRIMIDINE DERIVATIVES, PROCESS AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND PESTICIDES OR FUNGICIDES CONTAINING THESE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1998-12-09 EP disclosed
CN-1161687-A Phenylacetic acid alkyl esters BASF AG (DE) 1997-10-08 CN disclosed
WO-1997029093-A1 PYRIMIDINE DERIVATIVES, PROCESS AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND PESTICIDES OR FUNGICIDES CONTAINING THESE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1997-08-14 WO disclosed
US-4766219-A Preparation of 2-cyano-6-chloropyridine compounds THE DOW CHEMICAL COMPANY (US) 1988-08-23 US disclosed
US-4558134-A PICORNAVIRUS THE DOW CHEMICAL COMPANY (US) 1985-12-10 US disclosed
US-4112100-A INCREASING THE ENDOGENOUS PRODUCTION OF PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-09-05 US disclosed
US-4008326-A INCREASING PRODUCTION OF PROSTAGLANDINS THE UPJOHN COMPANY (US) 1977-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180037594-A1 Oxadiazolopyridine Derivates for Use as Ghrelin O-Acyl Transferase (GOAT) Inhibitors MBOAT4, GIPR, ACAT1 KDM4E 1715/4885ALDH1A1 223/4885POLB 4574/4885
US-10617675-B2 Hepatitis C virus inhibitors HAVCR2, MAVS, EIF2AK2 KDM4E 3572/4885ALDH1A1 3966/4885POLB 2041/4885
US-20180221342-A1 HEPATITIS C VIRUS INHIBITORS HAVCR2, MAVS, EIF2AK2 KDM4E 3572/4885ALDH1A1 3966/4885POLB 2041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.